Literature DB >> 23919533

Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient.

J M Cruzado1, S Gil-Vernet, J Castellote, O Bestard, E Melilli, J M Grinyó.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23919533     DOI： 10.1111/ajt.12400

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  5 in total

Review 1.  Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients.

Authors:  Akshay Shetty; Adam Buch; Sammy Saab
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

2.  Living kidney donation in individuals with hepatitis C and HIV infection: rationale and emerging evidence.

Authors:  Luckmini Liyanage; Abimereki D Muzaale; Macey L Henderson; Christine M Durand
Journal:  Curr Transplant Rep       Date:  2019-04-30

3.  Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.

Authors:  Krista L Lentine; John D Peipert; Tarek Alhamad; Yasar Caliskan; Beatrice P Concepcion; Rachel Forbes; Mark Schnitzler; Su-Hsin Chang; Matthew Cooper; Roy D Bloom; Roslyn B Mannon; David A Axelrod
Journal:  Kidney360       Date:  2020-11-25

4.  Assessment of 4 Cases of Kidney Transplantation from Hepatitis C Virus Antibody-Positive and RNA-Negative Donors to Antibody-Negative Recipients.

Authors:  Kohei Unagami; Hideki Ishida; Masayoshi Okumi; Toshihito Hirai; Daisuke Toki; Kazuya Omoto; Tomokazu Shimizu; Masashi Inui; Kosaku Nitta; Kazunari Tanabe
Journal:  Transplant Direct       Date:  2016-08-26

Review 5.  Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients.

Authors:  Armando Calogero; Evangelista Sagnelli; Massimiliano Creta; Silvia Angeletti; Gaia Peluso; Paola Incollingo; Maria Candida; Gianluca Minieri; Nicola Carlomagno; Concetta Anna Dodaro; Massimo Ciccozzi; Caterina Sagnelli
Journal:  Biomed Res Int       Date:  2019-04-07       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.